| Predicate |
Object |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D401-12 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D401-12 |
| filingDate |
2002-02-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a9159704035b30da37ba6abfde3b71d1
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f0e6371ba0d4805d6b10c5913a51dcd1
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_35b9532a2f58fa6cead18fdbb09a63ec
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6f80849c25e89b951edfbe5506f3965a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_09981fed12700fdf2d55206c1530c2cf |
| publicationDate |
2003-01-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-2003013711-A1 |
| titleOfInvention |
Chemical derivatives and their application as antitelomerase agents |
| abstract |
The present invention relates to cancer therapies using novel anticancer agents with a specific mechanism of action. The invention also relates to novel chemical compounds and their therapeutic application in man. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2004053966-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2007232572-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2009226411-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7482352-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2005070571-A1 |
| priorityDate |
2001-02-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |